Biosensors – How ???
Interesting – Biosensors sued by Boston Scientific, then Biosensors sued ACCS (subsidiary of Guidant, where Boston Scientific is trying to take over), and after that Boston Scientific received warning from FDA that will affect both Boston Scientific and Guidant’s share price.
Looks like Boston Scientific is not very reliable huh, Biosensors got a chance to win both cases 
Biosensors – 1.050
Boston Scientific – 21.99 down 5% at the moment
Guidant – 73.39 down 2.48% at the moment
BSX – http://finance.yahoo.com/q?s=bsx
GDT – http://finance.yahoo.com/q?d=t&s=GDT
——————————————
Biosensors is facing a lawsuit from US-based Boston Scientific and a Canadian company, Angiotech Pharmaceuticals.
The suits allege that Biosensors’ AxxionTM Stent infringes on a European patent owned by Angiotech.
The legal action was lodged in The Netherlands against Biosensors and some of its subsidiaries.
In a notice to the Singapore Exchange, Biosensors did not indicate the damages being sought.
It says it is consulting its legal advisers and intends to defend the claims made by Boston Scientific and Angiotech.
——————————————
Biosensors International Group said on Monday it is seeking damages of more than US$26.5 million from heart device maker Guidant Corp for a breach of agreement by Guidant Corporation subsidiary Advanced Cardiovascular Systems Inc.
More info : http://business-times.asia1.com.sg/sub/companies/story/0,4574,183817,00.html
——————————————
Boston Scientific received a stern warning from federal regulators a day after winning a $27 billion bidding war for Guidant, a maker of medical devices. The Food and Drug Administration said Boston Scientific had failed to tell the government about safety problems with its own devices. Boston Scientific shares are down on the news, threatening to lower the value of its offer to Guidant, which is to be paid partly in stock.
——————————————
